Mukherjee; Arnab

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mukherjee; Arnab.The latest application filed is for "network weather intelligence system".

Company Profile

2.12.15

Mukherjee; Arnab - West Bengal IN
Mukherjee; Arnab - Milpitas CA
Mukherjee; Arnab - Houston TX US
Mukherjee; Arnab - Salem CT
Mukherjee; Arnab - Ann Arbor MI
Mukherjee; Arnab - Saline MI
Mukherjee; Arnab - Memphis TN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Covalent organic framework films, and methods of making and uses of same Grant 11,213,800 - Dichtel , et al. January 4, 2	2022-01-04
Network Weather Intelligence System App 20210215848 - Mukherjee; Arnab ; et al.	2021-07-15
Distributed Architecture For Enabling Machine-learned Event Analysis On End User Devices App 20200082294 - Malhotra; Manish ; et al.	2020-03-12
Network Computing System For Real-time Event Analysis App 20200082288 - Malhotra; Manish ; et al.	2020-03-12
Covalent Organic Framework Films, And Methods Of Making And Uses Of Same App 20140037944 - Dichtel; William R. ; et al.	2014-02-06
High temperature fracturing fluids and methods Grant 8,450,252 - Funkhouser , et al. May 28, 2	2013-05-28
High temperature fracturing fluids and methods Grant 8,309,498 - Funkhouser , et al. November 13, 2	2012-11-13
High Temperature Fracturing Fluids and Methods App 20120208727 - Funkhouser; Gary P. ; et al.	2012-08-16
High Temperature Fracturing Fluids and Methods App 20110067875 - Funkhouser; Gary P. ; et al.	2011-03-24
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy App 20080193380 - Dalton; James T. ; et al.	2008-08-14
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy Grant 7,344,700 - Dalton , et al. March 18, 2	2008-03-18
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer Grant 7,129,377 - Miller , et al. October 31, 2	2006-10-31
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer Grant 7,041,844 - Miller , et al. May 9, 2	2006-05-09
Irreversible selective androgen receptor modulators and methods of use thereof App 20060035966 - Dalton; James T. ; et al.	2006-02-16
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer App 20040248862 - Miller, Duane D. ; et al.	2004-12-09
Irreversible selective androgen receptor modulators and methods of use thereof App 20040087810 - Dalton, James T. ; et al.	2004-05-06
Radiolableled selective androgen receptor modulators andtheir use in prostate cancer imaging and therapy App 20040052727 - Dalton, James T. ; et al.	2004-03-18
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer App 20030232882 - Miller, Duane D. ; et al.	2003-12-18
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer Grant 6,482,861 - Miller , et al. November 19, 2	2002-11-19
Non-steroidal Radiolabeled Agonist/antagonist Compounds And Their Use In Prostate Cancer Imaging App 20020098148 - MILLER, DUANE D. ; et al.	2002-07-25
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer App 20010012839 - Miller, Duane D ; et al.	2001-08-09
Non-steroidal agonist compounds and their use in male hormone therapy Grant 6,160,011 - Miller , et al. December 12, 2	2000-12-12
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer Grant 6,071,957 - Miller , et al. June 6, 2	2000-06-06
Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging Grant 6,019,957 - Miller , et al. February 1, 2	2000-02-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.